How to Play Gold Po...
Health Care: Drugs
Hyperion Therapeutics Inc (HPTX: NASDAQ)
$20.80 -0.84 | -3.88%
05/21/13 - 04:00 PM ET
86.52K / 122.80K
Vol / Avg. Vol:21.00 / 21.64
Open / Prev. Close:20.54 - 21.55
Today's Range:9.95 - 26.50
52 Wk Range:91.84%
Performance YTD:TheStreet Rating:
Portfolios with HPTX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
Latest HPTX Headlines from TheStreet
- Hyperion Therapeutics Added To NASDAQ Biotechnology Index (NBI) 05.16.13 | 04:05 pm
- Hyperion Therapeutics Announces First Quarter 2013 Operating Results 05.09.13 | 04:05 pm
- Hyperion Therapeutics To Report First Quarter 2013 Financial Results After Market On May 9, 2013 05.06.13 | 06:05 pm
- Hyperion Therapeutics Receives Orphan Drug Exclusivity From FDA 05.02.13 | 09:05 am
- Hyperion Therapeutics Exercises Option To Acquire Rights To BUPHENYL(R) And AMMONUL(R) 05.02.13 | 09:05 am
- Hyperion Therapeutics Becomes Oversold (HPTX) 05.01.13 | 12:05 pm
- Hyperion Therapeutics To Present At Needham's 12th Annual Healthcare Conference 04.25.13 | 04:04 pm
- Hyperion Therapeutics Issued Key Patent Pertaining To Use Of Fasting Ammonia 04.16.13 | 04:04 pm
- Hyperion Therapeutics Completes Follow-On Offering And Announces Exercise Of Underwriters' Over-Allotment Option 03.13.13 | 04:03 pm
- Hyperion Therapeutics Announces Pricing Of Follow-On Offering 03.08.13 | 09:03 am
Press Releases for HPTX
- Hyperion Therapeutics Completes Initial Public Offering And Announces Exercise Of Underwriters’ Over-Allotment Option - Business Wire 07.31.12 | 04:07 pm
- Hyperion Therapeutics Announces Pricing Of Initial Public Offering - Business Wire 07.26.12 | 08:07 am
Partner Headlines for HPTX
